Possible Regulation of the Conventional Calpain System by Skeletal Muscle-specific Calpain, p94/Calpain 3*

  1. Hiroyuki Sorimachi§§§
  1. Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, §CREST, Japan Science and Technology, Kawaguchi 332-0012, Japan, Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Mannheim, Mannheim 68167, Germany, and **Tokyo Metropolitan Institute of Gerontology, Tokyo 173-0015, Japan
  1. §§ To whom correspondence should be addressed: Laboratory of Biological Function, Dept. of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, the University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. Tel./Fax: 81-3-5841-8118; E-mail: ahsori{at}mail.ecc.u-tokyo.ac.jp.

Abstract

p94 (also called calpain 3) is the skeletal muscle-specific calpain and is considered to be a “modulator protease” in various cellular processes. Analysis of p94 at the protein level is an urgent issue because the loss of p94 protease activity causes limb-girdle muscular dystrophy type 2A. In this study, we enzymatically characterized one alternatively spliced variant of p94, p94:exons 61516 (p94Δ), which lacks two of the p94-specific insertion sequences. In contrast to p94, which has hardly been studied enzymatically due to its rapid, thorough, and apparently Ca2+-independent autolytic activity, p94Δ was stably expressed in COS and insect cells. p94Δ showed Ca2+-dependent caseinolytic and autolytic activities and an inhibitor spectrum similar to those of the conventional calpains. However, calpastatin did not inhibit p94Δ and is a substrate for p94Δ, which is consistent with the properties of p94, presenting p94 as a possible regulator of the conventional calpain system. We also established a semi-quantitative fluorescence resonance energy transfer assay using the calpastatin sequence specifically to measure p94 activity. This method detects the activity of COS-expressed p94 and p94Δ, suggesting that it has potential to evaluate p94 activity in vivo and in the diagnosis of limb-girdle muscular dystrophy type 2A.

  • Received August 8, 2003.
  • Revision received October 1, 2003.
Table of Contents

This Article

  1. The Journal of Biological Chemistry 279, 2761-2771.
  1. All Versions of this Article:
    1. M308789200v1
    2. 279/4/2761 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.